US 8951998
Quinoxaline-containing compounds as hepatitis C virus inhibitors
granted A61PA61P31/12A61P31/14
Quick answer
US patent 8951998 (Quinoxaline-containing compounds as hepatitis C virus inhibitors) held by Enanta Pharmaceuticals, Inc. expires Mon Feb 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Enanta Pharmaceuticals, Inc.
- Grant date
- Tue Feb 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61P, A61P31/12, A61P31/14, A61P43/00